H2O2 inhibits BCR-dependent immediate early induction of EBV genes in Burkitt's lymphoma cells

Free Radical Biology and Medicine

Volumn 47, Issue 8, 2009, Pages 1120-1129

  Osipova Goldberg, Helen I ^a   Turchanowa, Lyudmila V ^a   Adler, Barbara ^b   Pfeilschifter, Josef M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Akata cells; B lymphocytes; BCR; Burkitt's lymphoma; BZLF1; EBV reactivation; Free radicals; H2O2; IgG cross linking; Real time PCR; Superoxide

Indexed keywords

B LYMPHOCYTE RECEPTOR; CATALASE; DYE; HYDROGEN PEROXIDE; IMMEDIATE EARLY PROTEIN BZLF1; LUCIGENIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; BRLF1 PROTEIN, HUMAN HERPESVIRUS 4; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; IMMEDIATE EARLY PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; OXIDIZING AGENT; SUPEROXIDE; TRANSACTIVATOR PROTEIN;

ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGHT ABSORPTION; LYMPHOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; VIRUS REACTIVATION; WESTERN BLOTTING; DRUG EFFECT; EPSTEIN BARR VIRUS INFECTION; GENETICS; METABOLISM; PATHOGENICITY; TUMOR CELL CULTURE; VIROLOGY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 4;

BURKITT LYMPHOMA; CATALASE; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; HYDROGEN PEROXIDE; IMMEDIATE-EARLY PROTEINS; OXIDANTS; RECEPTORS, ANTIGEN, B-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDES; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 70349172668     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.06.019     Document Type: Article

References (47)

1. Amon W., Binne U.K., Bryant H., Jenkins P.J., Karstegl C.E., and Farrell P.J. Lytic cycle gene regulation of Epstein-Barr virus. J. Virol. 78 (2004) 13460-13469
2. Dolcetti R., Martini F., Quaia M., Gloghini A., Vignocchi B., Cariati R., Martinelli M., Carbone A., Boiocchi M., and Tognon M. Simian virus 40 sequences in human lymphoblastoid B-cell lines. J. Virol. 77 (2003) 1595-1597
3. Hochberg D., Souza T., Catalina M., Sullivan J.L., Luzuriaga K., and Thorley-Lawson D.A. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J. Virol. 78 (2004) 5194-5204
4. Laichalk L.L., and Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79 (2005) 1296-1307
5. Takada K., and Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63 (1989) 445-449
6. Rodriguez A., Jung E.J., and Flemington E.K. Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J. Virol. 75 (2001) 4482-4489
7. Bannister A.J., Cook A., and Kouzarides T. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene 6 (1991) 1243-1250
8. Flemington E., and Speck S.H. Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc. Natl. Acad. Sci. USA 87 (1990) 9459-9463
9. Farrell C.J., Lee J.M., Shin E.C., Cebrat M., Cole P.A., and Hayward S.D. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Proc. Natl. Acad. Sci. USA 101 (2004) 4625-4630
10. Bryant H., and Farrell P.J. Signal transduction and transcription factor modification during reactivation of Epstein-Barr virus from latency. J. Virol. 76 (2002) 10290-10298
11. Speck S.H., Chatila T., and Flemington E. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5 (1997) 399-405
12. Chang P.J., Chang Y.S., and Liu S.T. Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus. J. Virol. 72 (1998) 5128-5136
13. Hancock J.T., Maly F.E., and Jones O.T. Properties of the superoxide-generating oxidase of B-lymphocyte cell lines: determination of Michaelis parameters. Biochem. J. 262 (1989) 373-375
14. Leca G., Benichou G., Bensussan A., Mitenne F., Galanaud P., and Vazquez A. Respiratory burst in human B lymphocytes: triggering of surface Ig receptors induces modulation of chemiluminescence signal. J. Immunol. 146 (1991) 3542-3549
15. Saugstad O.D., Hallman M., Becher G., Oddoy A., Lium B., and Lachmann B. Respiratory failure caused by intratracheal saline: additive effect of xanthine oxidase. Biol. Neonate 54 (1988) 61-67
16. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3 (2002) 1129-1134
17. Pfeilschifter J., Eberhardt W., and Beck K.F. Regulation of gene expression by nitric oxide. Pflugers Arch. 442 (2001) 479-486
18. Mannick J.B., Asano K., Izumi K., Kieff E., and Stamler J.S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79 (1994) 1137-1146
19. Gao X., Tajima M., and Sairenji T. Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines. Virology 258 (1999) 375-381
20. Cerimele F., Battle T., Lynch R., Frank D.A., Murad E., Cohen C., Macaron N., Sixbey J., Smith K., Watnick R.S., Eliopoulos A., Shehata B., and Arbiser J.L. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc. Natl. Acad. Sci. USA 102 (2005) 175-179
21. Leca G., Joly F., Vazquez A., Galanaud P., and Ninio E. Paf-acether-induced superoxide anion generation in human B cell line. FEBS Lett. 269 (1990) 171-173
22. Pronai L., Nakazawa H., Ichimori K., Saigusa Y., Ohkubo T., Hiramatsu K., Arimori S., and Feher J. Time course of superoxide generation by leukocytes-the MCLA chemiluminescence system. Inflammation 16 (1992) 437-450
23. Rinaldi M., Moroni P., Paape M.J., and Bannerman D.D. Evaluation of assays for the measurement of bovine neutrophil reactive oxygen species. Vet. Immunol. Immunopathol. 115 (2007) 107-125
24. Krishna M.C., Russo A., Mitchell J.B., Goldstein S., Dafni H., and Samuni A. Do nitroxide antioxidants act as scavengers of O2•- or as SOD mimics?. J. Biol. Chem. 271 (1996) 26026-26031
25. Barbouti A., Doulias P.T., Nousis L., Tenopoulou M., and Galaris D. DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2. Free Radic. Biol. Med. 33 (2002) 691-702
26. Packham G., Brimmell M., Cook D., Sinclair A.J., and Farrell P.J. Strain variation in Epstein-Barr virus immediate early genes. Virology 192 (1993) 541-550
27. Takada K., Horinouchi K., Ono Y., Aya T., Osato T., Takahashi M., and Hayasaka S. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5 (1991) 147-156
28. Yin Q., Jupiter K., and Flemington E.K. The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-β1 mediated reactivation. Virology 327 (2004) 134-143
29. Hosaka S., Obuki M., Nakajima J., and Suzuki M. Comparative study of antioxidants as quenchers or scavengers of reactive oxygen species based on quenching of MCLA-dependent chemiluminescence. Luminescence 20 (2005) 419-427
30. Lucas M., and Solano F. Coelenterazine is a superoxide anion-sensitive chemiluminescent probe: its usefulness in the assay of respiratory burst in neutrophils. Anal. Biochem. 206 (1992) 273-277
31. Teranishi K., and Shimomura O. Coelenterazine analogs as chemiluminescent probe for superoxide anion. Anal. Biochem. 249 (1997) 37-43
32. Quick K.L., Hardt J.I., and Dugan L.L. Rapid microplate assay for superoxide scavenging efficiency. J. Neurosci. Methods 97 (2000) 139-144
33. Chanock S.J., el Benna J., Smith R.M., and Babior B.M. The respiratory burst oxidase. J. Biol. Chem. 269 (1994) 24519-24522
34. Kobayashi S., Imajoh-Ohmi S., Kuribayashi F., Nunoi H., Nakamura M., and Kanegasaki S. Characterization of the superoxide-generating system in human peripheral lymphocytes and lymphoid cell lines. J. Biochem. 117 (1995) 758-765
35. Krishna M.C., Samuni A., Taira J., Goldstein S., Mitchell J.B., and Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins: kinetics and mechanism. J. Biol. Chem. 271 (1996) 26018-26025
36. Shacter E., Williams J.A., Hinson R.M., Senturker S., and Lee Y.J. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood 96 (2000) 307-313
37. Samuni A., Mitchell J.B., DeGraff W., Krishna C.M., Samuni U., and Russo A. Nitroxide SOD-mimics: modes of action. Free Radic. Res. Commun. 12-13 Pt. 1 (1991) 187-194
38. Hahn S.M., Mitchell J.B., and Shacter E. Tempol inhibits neutrophil and hydrogen peroxide-mediated DNA damage. Free Radic. Biol. Med. 23 (1997) 879-884
39. Faulkner K.M., Liochev S.I., and Fridovich I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J. Biol. Chem. 269 (1994) 23471-23476
40. Kawakami N., Takemasa H., Okamura N., Hayakawa T., Shimohama S., and Fujimoto S. Participation of cytosolic protein phosphatase in regulation of NADPH oxidase in polymorphonuclear leukocytes. Biol. Pharm. Bull. 22 (1999) 556-560
41. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radic. Biol. Med. 33 (2002) 774-797
42. Dikalov S.I., Dikalova A.E., Bikineyeva A.T., Schmidt H.H., Harrison D.G., and Griendling K.K. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic. Biol. Med. 45 (2008) 1340-1351
43. Flemington E., and Speck S.H. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64 (1990) 1227-1232
44. Feederle R., and Delecluse H.J. Low level of lytic replication in a recombinant Epstein-Barr virus carrying an origin of replication devoid of BZLF1-binding sites. J. Virol. 78 (2004) 12082-12084
45. Feng W.H., Hong G., Delecluse H.J., and Kenney S.C. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J. Virol. 78 (2004) 1893-1902
46. Daibata M., Bandobashi K., Kuroda M., Imai S., Miyoshi I., and Taguchi H. Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo. J. Virol. 79 (2005) 5875-5879
47. Kenney S., and Theodore E. Development of novel, EBV-targeted therapies for EBV-positive tumors. Trans. Am. Clin. Climatol. Assoc. 117 (2006) 55-73 discussion 73-74